Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Apple
AAPL
|
+$2.94B |
| 2 |
Amazon
AMZN
|
+$1.22B |
| 3 |
NVIDIA
NVDA
|
+$1.11B |
| 4 |
Microsoft
MSFT
|
+$1.01B |
| 5 |
Procter & Gamble
PG
|
+$784M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$619M |
| 2 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$582M |
| 3 |
Phillips 66
PSX
|
+$575M |
| 4 |
Eli Lilly
LLY
|
+$377M |
| 5 |
HES
Hess
HES
|
+$326M |
Sector Composition
| 1 | Technology | 31.4% |
| 2 | Financials | 12.71% |
| 3 | Consumer Discretionary | 10.47% |
| 4 | Healthcare | 9.99% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Avidity Biosciences
RNA
$5.76B
| $3.16M | ﹤0.01% |
123,946
-74,168
| -37% | -$1.89M |
|
1602
Genworth Financial
GNW
$3.61B
| $3.16M | ﹤0.01% |
491,913
-311,285
| -39% | -$2M |
|
1603
Doximity
DOCS
$13.3B
| $3.16M | ﹤0.01% |
117,309
+15,530
| +15% | +$418K |
|
1604
Otter Tail
OTTR
$3.48B
| $3.16M | ﹤0.01% |
36,536
-27,640
| -43% | -$2.39M |
|
1605
WesBanco
WSBC
$3.03B
| $3.15M | ﹤0.01% |
105,740
-39,381
| -27% | -$1.17M |
|
1606
Enpro
NPO
$4.64B
| $3.15M | ﹤0.01% |
18,660
-14,472
| -44% | -$2.44M |
|
1607
Jamf
JAMF
$1.41B
| $3.14M | ﹤0.01% |
171,012
-83,534
| -33% | -$1.53M |
|
1608
Granite Construction
GVA
$4.7B
| $3.14M | ﹤0.01% |
54,881
-19,676
| -26% | -$1.12M |
|
1609
Recursion Pharmaceuticals
RXRX
$2.11B
| $3.13M | ﹤0.01% |
314,301
-282,257
| -47% | -$2.81M |
|
|
TCN
1610
DELISTED
Tricon Residential Inc.
TCN
| $3.13M | ﹤0.01% |
280,819
+233,851
| +498% | +$2.61M |
|
1611
CareTrust REIT
CTRE
$7.62B
| $3.13M | ﹤0.01% |
128,437
-48,937
| -28% | -$1.19M |
|
|
BWIN
1612
Baldwin Insurance Group
BWIN
$2.22B
| $3.12M | ﹤0.01% |
107,759
+13,260
| +14% | +$384K |
|
1613
VanEck Oil Services ETF
OIH
$850M
| $3.12M | ﹤0.01% |
9,264
| – | – |
|
1614
Amphastar Pharmaceuticals
AMPH
$1.3B
| $3.11M | ﹤0.01% |
70,832
+7,590
| +12% | +$333K |
|
1615
Denali Therapeutics
DNLI
$2.07B
| $3.11M | ﹤0.01% |
151,560
-172,459
| -53% | -$3.54M |
|
1616
iShares TIPS Bond ETF
TIP
$14B
| $3.11M | ﹤0.01% |
28,949
-174
| -0.6% | -$18.7K |
|
1617
First Financial Bancorp
FFBC
$2.46B
| $3.11M | ﹤0.01% |
138,645
-51,334
| -27% | -$1.15M |
|
1618
FB Financial Corp
FBK
$2.86B
| $3.11M | ﹤0.01% |
82,477
-22,773
| -22% | -$858K |
|
1619
Steven Madden
SHOO
$2.26B
| $3.1M | ﹤0.01% |
73,356
-78,292
| -52% | -$3.31M |
|
1620
HUB Group
HUBG
$2.2B
| $3.1M | ﹤0.01% |
71,678
-45,576
| -39% | -$1.97M |
|
1621
Myriad Genetics
MYGN
$674M
| $3.09M | ﹤0.01% |
145,079
-54,116
| -27% | -$1.15M |
|
1622
NovaGold Resources
NG
$2.82B
| $3.09M | ﹤0.01% |
1,030,660
+2,934
| +0.3% | +$8.8K |
|
1623
ADT
ADT
$7.24B
| $3.09M | ﹤0.01% |
459,626
-50,557
| -10% | -$340K |
|
1624
Sotera Health
SHC
$4.56B
| $3.09M | ﹤0.01% |
257,082
+21,328
| +9% | +$256K |
|
1625
Concentrix
CNXC
$3.4B
| $3.09M | ﹤0.01% |
46,604
+4,689
| +11% | +$310K |
|